Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DiaSorin Marks Significant Growth in Molecular Extraction Kit Sales

Published: Friday, February 14, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
Italian Voden Medical Instruments S.p.A. awarded DiaSorin Platinum Distributor status.

The Milan-based Life Science Division of Voden Medical Instruments S.p.A. has been awarded DiaSorin Platinum Distributor status in recognition of their outstanding contribution to sales of the DiaSorin Arrow instrument and molecular extraction kits throughout Italy.

Meeting the specific needs of HLA (human leukocyte antigen) testing laboratories, assessing tissue compatibility in organ transplant patients, the Arrow Blood DNA extraction kit has shown particular growth and completes the Voden product offering for this important molecular investigation.

“We value the role of our Distributors in promoting and selling DiaSorin products at a local level,” comments Paul Eros, Global Vice President Molecular, DiaSorin. "We have seen extraordinary growth in the sales of Arrow extraction kits in Italy over the last year and we are delighted to recognize the efforts of Voden Medical Instruments in maximizing opportunities for Arrow products in Italy’s Life Science market.”

“The Arrow extraction kits have given us a good entry into the HLA laboratory market and have presented opportunities to promote and sell other products in our portfolio,” comments Andrea Dell’ Acqua, Division Manager, Voden. “The ability to automate routine tasks in the laboratory is what our customers want and the Arrow range allows us to meet this need.”

“The Arrow extraction kits not only meet the need for standardization in the laboratory but they also offer flexibility,” adds Claudio Mazzei, Sales and Applications Manager, Voden, “The Arrow instrument allows between one and 12 samples to be processed at a time, with no waste of reagents for smaller batches. Other kits don’t have this flexibility. The instrument is fully automated and very easy to use. This, combined with the flexibility to process individual samples, is ideal if an urgent transplant sample comes in during the night and needs to be analyzed quickly.”

“The small footprint of the Arrow instrument is ideal,” continues Claudio Mazzei. “Both for our customers, who may have limited space or who might want to move the instrument from one lab to another, and for our sales team who can easily transport the machine for demonstration purposes. The support that DiaSorin provides is exemplary, giving us confidence that we can respond to our customers very quickly. In particular the training facilities in Dublin are excellent and the training very thorough and professional.”

“The DiaSorin Arrow instrument and extraction assays have helped to grow our business in the HLA laboratory market and have enabled us to offer Life Science customers the complete solution,” concludes Andrea Dell ‘Acqua. “We are confident that, as a major global diagnostics company, DiaSorin will continue to develop the product range, which will help us to have a greater presence in the Life Science market. For example, we are eagerly awaiting the new kit for the extraction of RNA from blood that DiaSorin is currently developing, which will help us to enhance our offering for other applications and to further increase our potential market.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!